Status:
COMPLETED
A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Boston Scientific Corporation
Wellframe, Inc.
Conditions:
Percutaneous Coronary Intervention
Eligibility:
All Genders
21-85 years
Phase:
NA
Brief Summary
The investigators aim to evaluate Wellframe, a patient engagement platform that includes a mobile phone application for patients, for its impact on supporting patients who have undergone a percutaneou...
Eligibility Criteria
Inclusion
- English-speaking PCI: balloon angioplasty, bare-metal stent, or drug-eluting stent at MGH Smartphone or Tablet (iOS or Android)
Exclusion
- Recent (within 1mo) illicit substance use or alcohol abuse In-hospital AMI Known pregnancy Dementia or cognitive disability Incarceration
Key Trial Info
Start Date :
February 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2019
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT03416920
Start Date
February 12 2018
End Date
August 20 2019
Last Update
July 17 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02114
2
Massachusetss General Hospital
Boston, Massachusetts, United States, 02114